Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am Heart J. 2017 Jul 12;191:82–90. doi: 10.1016/j.ahj.2017.07.003

Table 3.

Clinical Characteristics of study sample by Tertiles of SBP Reactivity.

Characteristic (N=199) High Reactors
(N=67)		 Intermediate
Reactors (N=65)		 Low Reactors
(N=67)		 P value
Age (years) 57.7 ± 11.7 56.0 ± 12.5 57.1 ± 12.8 0.73
BMI (kg/m2) 30.5 ± 6.49 32.19 ± 7.13a,c 30.5 ± 7.06 0.58
Race (% White) 45.2 46.2 58.5 0.14
Gender (% Female) 32.3 29.2 33.8 0.94
Pro BNP (pg/ml) 1110.5 ± 1597.4 1830.7 ± 2715.3 2350.0 ± 3480.2a 0.03
LVEF (%) 33.4 ± 10.1 31.6 ± 12.7 29.9 ± 10.9a 0.10
Etiology (% ischemic) 40.3 44.6 43.1 0.91
Diabetes (%) 32.3 46.2 50.8a 0.07
Beta Blocker (%) 90.3 89.2 83.1 0.50
a

– significantly different from high reactors (p < .05);

b

– significantly different from intermediate reactors (p < .05);

c

– significantly different from low reactors (p < .05)